Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-07

FDA Approved: PREGABALIN — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for Pregabalin from Torrent Pharmaceuticals Limited, enabling the generic drug to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)